1. Home
  2. OFIX vs EVMN Comparison

OFIX vs EVMN Comparison

Compare OFIX & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

N/A

Current Price

$6.06

Market Cap

292.2M

Sector

Health Care

ML Signal

N/A

Logo Evommune Inc.

EVMN

Evommune Inc.

N/A

Current Price

$7.03

Market Cap

284.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFIX
EVMN
Founded
1987
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.2M
284.5M
IPO Year
1998
2025

Fundamental Metrics

Financial Performance
Metric
OFIX
EVMN
Price
$6.06
$7.03
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$10.00
★ $21.89
AVG Volume (30 Days)
615.6K
★ 942.1K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
★ 75.23
EPS
★ N/A
N/A
Revenue
★ $822,312,000.00
$13,000,000.00
Revenue This Year
$0.58
N/A
Revenue Next Year
N/A
$40.00
P/E Ratio
★ N/A
N/A
Revenue Growth
2.85
★ 85.71
52 Week Low
$6.22
$4.94
52 Week High
$16.42
$33.20

Technical Indicators

Market Signals
Indicator
OFIX
EVMN
Relative Strength Index (RSI) 27.25 50.80
Support Level N/A $4.94
Resistance Level $10.35 $7.21
Average True Range (ATR) 0.64 0.65
MACD -0.20 0.09
Stochastic Oscillator 0.50 41.48

Price Performance

Historical Comparison
OFIX
EVMN

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: